Active Transport, Cell Nucleus
"Active Transport, Cell Nucleus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Gated transport mechanisms by which proteins or RNA are moved across the NUCLEAR MEMBRANE.
| Descriptor ID |
D021581
|
| MeSH Number(s) |
G03.143.310.100 G03.143.700.100
|
| Concept/Terms |
Active Transport, Cell Nucleus- Active Transport, Cell Nucleus
- Nucleo-cytoplasmic Transport
- Nucleo cytoplasmic Transport
- Transport, Nucleo-cytoplasmic
- Transports, Nucleo-cytoplasmic
- Nucleocytoplasmic Transport
- Transport, Nucleocytoplasmic
- Nuclear Transport
- Transport, Nuclear
|
Below are MeSH descriptors whose meaning is more general than "Active Transport, Cell Nucleus".
Below are MeSH descriptors whose meaning is more specific than "Active Transport, Cell Nucleus".
This graph shows the total number of publications written about "Active Transport, Cell Nucleus" by people in this website by year, and whether "Active Transport, Cell Nucleus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2006 | 0 | 2 | 2 |
| 2007 | 0 | 3 | 3 |
| 2008 | 0 | 1 | 1 |
| 2010 | 0 | 2 | 2 |
| 2011 | 0 | 2 | 2 |
| 2013 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 10 | 12 |
| 2018 | 2 | 12 | 14 |
| 2019 | 1 | 2 | 3 |
| 2020 | 0 | 3 | 3 |
| 2021 | 1 | 2 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Active Transport, Cell Nucleus" by people in Profiles.
-
SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms. PLoS One. 2021; 16(6):e0253089.
-
Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo. Antiviral Res. 2021 08; 192:105115.
-
How SARS-CoV-2 and Other Viruses Build an Invasion Route to Hijack the Host Nucleocytoplasmic Trafficking System. Cells. 2021 06 07; 10(6).
-
SARS-CoV-2 ORF6 Disrupts Bidirectional Nucleocytoplasmic Transport through Interactions with Rae1 and Nup98. mBio. 2021 04 13; 12(2).
-
Repurposing Ivermectin for COVID-19: Molecular Aspects and Therapeutic Possibilities. Front Immunol. 2021; 12:663586.
-
Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression. Sci Adv. 2021 02; 7(6).
-
Overexpression of SARS-CoV-2 protein ORF6 dislocates RAE1 and NUP98 from the nuclear pore complex. Biochem Biophys Res Commun. 2021 01 15; 536:59-66.
-
EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2. PLoS One. 2020; 15(11):e0241739.
-
SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling. Proc Natl Acad Sci U S A. 2020 11 10; 117(45):28344-28354.
-
The pharmacological development of direct acting agents for emerging needed therapy against severe acute respiratory syndrome coronavirus-2. J Chin Med Assoc. 2020 08; 83(8):712-718.